Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-15-006593
Filing Date
2015-12-01
Accepted
2015-12-01 09:05:18
Documents
2
Period of Report
2015-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 3833
2 PRESS RELEASE newsrelease.htm EX-99 5924
  Complete submission text file 0001171843-15-006593.txt   10763
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 151261312
SIC: 2834 Pharmaceutical Preparations